Authorizes the administration of the mpox vaccine by a pharmacist or a certified nurse practitioner.
This bill amends the Education Law to expressly add the mpox vaccine to the list of immunizations that may be administered by licensed pharmacists and certified nurse practitioners under existing patient-specific orders or non-patient-specific regimens. It updates three separate provisions governing pharmacists and nurse practitioners so that mpox is treated the same as other vaccines already authorized in those settings, such as influenza, COVID-19, measles, mumps, varicella, hepatitis A and B, meningococcal, tetanus, diphtheria, pertussis, pneumococcal, herpes zoster, and HPV.
The bill also preserves the existing framework that limits administration to authorized professionals acting within regulations and public health requirements, and it keeps the commissioner of health involved in determining when additional immunizations may be administered by pharmacists. It does not create a new vaccination program; rather, it expands the list of vaccines that can be provided through existing pharmacy and nurse practitioner channels, and it takes effect immediately upon enactment.
The bill would amend sections 6527, 6802, and 6909 of the Education Law to include mpox among the immunizations that pharmacists and certified nurse practitioners may administer pursuant to authorized orders or regimens. In practical terms, this would broaden access to mpox vaccination in pharmacies and other settings where these professionals already provide immunizations, while leaving intact the statutory and regulatory safeguards governing scope of practice, age limits, and emergency anaphylaxis treatment. It would affect licensed pharmacists, certified nurse practitioners, physicians issuing orders, and patients seeking vaccination, especially adults eligible for mpox vaccination under public health guidance.
Based on the bill text and the absence of recorded committee debate or votes in the provided materials, the measure appears to be a straightforward public health expansion with no documented opposition in the available record. The caption and drafting suggest a targeted technical update intended to align state law with current immunization needs and practice. The overall sentiment is therefore best characterized as neutral-to-supportive, with the bill framed as improving vaccine access through existing providers.
No specific points of contention are reflected in the provided committee transcripts or voting history, and no votes are listed. Potential areas of debate, if raised, would likely concern pharmacy scope of practice, the safety and appropriateness of authorizing additional vaccines through pharmacists and nurse practitioners, and the role of the commissioner of health in determining when other immunizations may be added. However, none of those issues are documented in the supplied materials, and the bill itself maintains existing limits by requiring authorized orders, regulations, and professional oversight.